GlassScriptPhysician profile
Dennis L Simpson
NPI 1316979644
$454.05
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $55.49 · 2023: $49.33 · 2024: $15.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $64.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $64.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.14 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $52.05 | 2019 | |
| Lilly USA, LLC | $37.26 | 2019 | |
| Astellas Pharma US INC | $36.26 | 2019-2020 | |
| Therapeuticsmd, INC. | $28.82 | 2019 | |
| Sanofi Pasteur INC. | $26.86 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $22.47 | 2023 | Eliquis |
| Acorda Therapeutics, INC | $18.37 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.24 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $15.29 | 2024 | Rexulti |
| Genentech USA, INC. | $15.04 | 2020 | |
| Glaxosmithkline, LLC. | $14.44 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.36 | 2019 | |
| Amgen INC. | $11.83 | 2019 | |
| Novo Nordisk INC | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.